Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 AUD | -3.51% |
|
+7.84% | -50.00% |
07-10 | Imugene Commences Patient Dosing in Phase 1 Bile Tract Cancer Trial; Shares Up 8% | MT |
06-24 | Imugene Doses First Patient of Bile Tract Cancer in Phase One Clinical Trial; Shares Decline 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.00% | 284M | |
+22.15% | 46.56B | |
+45.32% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- IMU Stock
- News Imugene Limited
- Imugene Commences Patient Dosing in Phase 1 Bile Tract Cancer Trial; Shares Up 8%